![]() |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for HMG20B |
Gene summary |
| Basic gene information | Gene symbol | HMG20B |
| Gene name | high mobility group 20B | |
| Synonyms | BRAF25|BRAF35|HMGX2|HMGXB2|PP7706|SMARCE1r|SOXL|pp8857 | |
| Cytomap | UCSC genome browser: 19p13.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_006339.2, | |
| Description | BRCA2-associated factor 35HMG box domain containing 2HMG box-containing protein 20BHMG domain-containing protein 2HMG domain-containing protein HMGX2SMARCE1-related proteinSWI/SNF-related matrix-associated actin-dependent regulator of chromatin subf | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 605535 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000064961 | ||
| HPRD : 05703 | ||
| Vega : OTTHUMG00000150437 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_HMG20B | |
| BioGPS: 10362 | ||
| Pathway | NCI Pathway Interaction Database: HMG20B | |
| KEGG: HMG20B | ||
| REACTOME: HMG20B | ||
| Pathway Commons: HMG20B | ||
| Context | iHOP: HMG20B | |
| ligand binding site mutation search in PubMed: HMG20B | ||
| UCL Cancer Institute: HMG20B | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | ||
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | ProstateSkin | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | PRADSKCM | |
| Reference showing the relevant tissue of HMG20B | ||
| Description by TissGene annotations | TissgsLTS | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for HMG20B |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
![]() |
Gene expressions across normal tissues of GTEx data(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
![]() |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| Top |
| TissGene-miRNA for HMG20B |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for HMG20B |
| TissGeneSNV for HMG20B |
nsSNV counts per each loci.Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
![]() |
![]() |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
![]() |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.Q225H | ESCA | 1 |
| p.S52F | CESC | 1 |
| p.S23F | UCEC | 1 |
| p.E190K | HNSC | 1 |
| p.E42Q | BLCA | 1 |
| p.H23Q | SKCM | 1 |
| p.E299K | HNSC | 1 |
| p.F192L | PAAD | 1 |
| p.F192V | UCEC | 1 |
| p.T90M | COAD | 1 |
| p.E190K | BLCA | 1 |
| p.F192L | BLCA | 1 |
| p.V303I | UCEC | 1 |
| p.P275S | COAD | 1 |
| p.V303I | GBM | 1 |
| Top |
| TissGeneCNV for HMG20B |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
![]() |
| Top |
| TissGeneFusions for HMG20B |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | AF370429 | NBPF9-HMG20B | chr1:145039771 | chr19:3572974 | |
| Chimerdb3.0 | ChiTaRs | NA | DA559284 | HIST1H2AJ-HMG20B | chr6:27782555 | chr19:3572994 | |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-IG-A50L-01A | HMG20B-CSAG2 | Out-of-Frame | chr19:3573798 | chrX:151928358 |
| Top |
| TissGeneNet for HMG20B |
Co-expressed gene networks based on protein-protein interaction data (CePIN)(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for HMG20B |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
![]() |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
| Top |
| TissGeneClin for HMG20B |
| TissGeneDrug for HMG20B |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for HMG20B |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0017638 | Glioma | 1 | LHGDN |
| umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
| umls:C0684249 | Carcinoma of lung | 1 | BeFree |